Skip to main content
SpringerLink
Log in

Impact of Sustained Virological Response to Interferon Therapy on Recurrence of Hepatitis C Virus-Related Hepatocellular Carcinoma

  • Hepatobiliary Tumors
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

Although achieving a sustained virological response (SVR) in hepatitis C virus (HCV) infection is recognized as improving liver function and reducing hepatocellular carcinoma (HCC) development, its impact on HCC recurrence is unclear. This study investigated how preoperative SVR achievement by interferon treatment affects HCC recurrence in patients undergoing hepatic resection.

Methods

The study subjects were 521 patients with HCV infection who underwent initial and curative hepatic resection for HCC. To adjust for confounding factors between the SVR and non-SVR groups, propensity score-matching analysis was performed.

Results

After propensity score matching, 45 of the 49 patients in the SVR group, and an equal number of the 472 patients in the non-SVR group, were matched. The two groups had similar distributions of clinicopathological characteristics. In the matched cohort, the 3-, 5-, and 7-year recurrence-free survival rates after surgery were 56, 45, and 37%, respectively, in the SVR group, and 34, 23, and 7.2%, respectively, in the non-SVR group (p = 0.033). Additionally, the 3-, 5-, and 7-year overall survival rates after surgery were 82, 80, and 75%, respectively, in the SVR group, and 78, 64, and 44%, respectively, in the non-SVR group (p = 0.065). The 1- and 2-year cumulative recurrence rates in the early phase showed no significant difference between the SVR and non-SVR groups (p = 0.27). however, the 3-, 5-, and 7-year cumulative recurrence rates in the late phase were 14, 32, and 43%, respectively, in the SVR group, and 33, 55, and 86%, respectively, in the non-SVR group (p = 0.037).

Conclusion

Achievement of SVR may reduce postoperative recurrence after hepatic resection.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Nathan H, Segev DL, Mayo SC, et al. National trends in surgical procedures for hepatocellular carcinoma: 1998–2008. Cancer. 2012; 118:1838–44.

    Article  PubMed  Google Scholar 

  2. D’Ambrosio R, Della Corte C, Colombo M. Hepatocellular carcinoma in patients with a sustained response to anti-hepatitis C therapy. Int J Mol Sci. 2015; 16:19698–712.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Shindoh J, Hasegawa K, Inoue Y, et al. Risk factors of post-operative recurrence and adequate surgical approach to improve long-term outcomes of hepatocellular carcinoma. HPB (Oxford). 2013; 15:31–9.

    Article  PubMed  Google Scholar 

  4. Miyatake H, Kobayashi Y, Iwasaki Y, et al. Effect of previous interferon treatment on outcome after curative treatment for hepatitis C virus-related hepatocellular carcinoma. Dig Dis Sci. 2012; 57:1092–101.

    Article  CAS  PubMed  Google Scholar 

  5. Yoshida H, Shiratori Y, Moriyama M, et al. Interferon therapy reduces the risk for hepatocellular carcinoma: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan. IHIT Study Group. Inhibition of hepatocarcinogenesis by interferon therapy. Ann Intern Med. 1999; 131:174–81.

    Article  CAS  PubMed  Google Scholar 

  6. Conti F, Buonfiglioli F, Scuteri A, et al. Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals. J Hepatol. 2016;65:727–33.

    Article  CAS  PubMed  Google Scholar 

  7. Tokita H, Fukui H, Tanaka A, et al. Risk factors for the development of hepatocellular carcinoma among patients with chronic hepatitis C who achieved a sustained virological response to interferon therapy. J Gastroenterol Hepatol. 2005; 20:752–8.

    Article  CAS  PubMed  Google Scholar 

  8. Nagaoki Y, Aikata H, Nakano N, et al. Development of hepatocellular carcinoma in patients with hepatitis C virus infection who achieved sustained virological response following interferon therapy: a large-scale, long-term cohort study. J Gastroenterol Hepatol. 2016; 31:1009–15.

    Article  CAS  PubMed  Google Scholar 

  9. Shiratori Y, Imazeki F, Moriyama M, et al. Histologic improvement of fibrosis in patients with hepatitis C who have sustained response to interferon therapy. Ann Intern Med. 2000; 132:517–24.

    Article  CAS  PubMed  Google Scholar 

  10. Saito T, Chiba T, Suzuki E, et al. Effect of previous interferon-based therapy on recurrence after curative treatment of hepatitis C virus-related hepatocellular carcinoma. Int J Med Sci. 2014; 11:707–12.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Sakae M, Kubo S, Takemura S, et al. Effect of interferon therapy on first and second recurrence after resection of hepatitis C virus-related hepatocellular carcinoma. Hepatol Res. 2012; 42:564–73.

    Article  CAS  PubMed  Google Scholar 

  12. Shindoh J, Hasegawa K, Matsuyama Y, et al. Low hepatitis C viral load predicts better long-term outcomes in patients undergoing resection of hepatocellular carcinoma irrespective of serologic eradication of hepatitis C virus. J Clin Oncol. 2013; 31:766–73.

    Article  PubMed  Google Scholar 

  13. Portolani N, Coniglio A, Ghidoni S, et al. Early and late recurrence after liver resection for hepatocellular carcinoma: prognostic and therapeutic implications. Ann Surg. 2006; 243:229–35.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Imamura H, Matsuyama Y, Tanaka E, et al. Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. J Hepatol. 2003; 38:200–7.

    Article  PubMed  Google Scholar 

  15. Hasegawa K, Kokudo N, Imamura H, et al. Prognostic impact of anatomic resection for hepatocellular carcinoma. Ann Surg. 2005; 242:252–9.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Makuuchi M, Kosuge T, Takayama T, et al. Surgery for small liver cancers. Semin Surg Oncol. 1993; 9:298–304.

    Article  CAS  PubMed  Google Scholar 

  17. Kudo M, Kitano M, Sakurai T, et al. General rules for the clinical and pathological study of primary liver cancer, nationwide follow-up survey and clinical practice guidelines: the outstanding achievements of the Liver Cancer Study Group of Japan. Dig Dis. 2015; 33:765–70.

    Article  PubMed  Google Scholar 

  18. Leyrat C, Caille A, Donner A, et al. Propensity score methods for estimating relative risks in cluster randomized trials with low-incidence binary outcomes and selection bias. Stat Med 2014; 33:3556–75.

    Article  PubMed  Google Scholar 

  19. Kumada T, Nakano S, Takeda I, et al. Patterns of recurrence after initial treatment in patients with small hepatocellular carcinoma. Hepatology. 1997; 25:87–92.

    Article  CAS  PubMed  Google Scholar 

  20. Poon RT, Fan ST, Ng IO, et al. Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma. Cancer. 2000; 89:500–7.

    Article  CAS  PubMed  Google Scholar 

  21. Ueno M, Uchiyama K, Ozawa S, et al. Adjuvant chemolipiodolization reduces early recurrence derived from intrahepatic metastasis of hepatocellular carcinoma after hepatectomy. Ann Surg Oncol. 2011;18:3624–31.

    Article  PubMed  Google Scholar 

  22. Mazzaferro V, Romito R, Schiavo M, et al. Prevention of hepatocellular carcinoma recurrence with alpha-interferon after liver resection in HCV cirrhosis. Hepatology. 2006; 44:1543–54.

    Article  CAS  PubMed  Google Scholar 

  23. Shiratori Y, Shiina S, Teratani T, et al. Interferon therapy after tumor ablation improves prognosis in patients with hepatocellular carcinoma associated with hepatitis C virus. Ann Intern Med. 2003; 138:299–306.

    Article  PubMed  Google Scholar 

  24. Peiffer KH, Sarrazin C. The importance of HCV RNA measurement for tailoring treatment duration. Dig Liver Dis. 2013; 45 Suppl 5:S323–31.

    Article  CAS  PubMed  Google Scholar 

Download references

Disclosures

The authors declare no conflict of interest.

Author information

Authors and Affiliations

  1. Hepatobiliary-Pancreatic Surgery Division, Department of Surgery, Graduate School of Medicine, University of Tokyo, Tokyo, Japan

    Hiroji Shinkawa MD, PhD, Kiyoshi Hasegawa MD, PhD, Junichi Arita MD, PhD, Nobuhisa Akamatsu MD, PhD, Junichi Kaneko MD, PhD, Yoshihiro Sakamoto MD, PhD & Norihiro Kokudo MD, PhD

Authors
  1. Hiroji Shinkawa MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kiyoshi Hasegawa MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Junichi Arita MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Nobuhisa Akamatsu MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Junichi Kaneko MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yoshihiro Sakamoto MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Norihiro Kokudo MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kiyoshi Hasegawa MD, PhD.

Electronic supplementary material

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Shinkawa, H., Hasegawa, K., Arita, J. et al. Impact of Sustained Virological Response to Interferon Therapy on Recurrence of Hepatitis C Virus-Related Hepatocellular Carcinoma. Ann Surg Oncol 24, 3196–3202 (2017). https://doi.org/10.1245/s10434-017-6008-y

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-017-6008-y

Keywords

Search

Navigation